Sales decline 12.02% to Rs 172.43 crore
Net profit of Bliss GVS Pharma declined 34.88% to Rs 13.85 crore in the quarter ended September 2022 as against Rs 21.27 crore during the previous quarter ended September 2021. Sales declined 12.02% to Rs 172.43 crore in the quarter ended September 2022 as against Rs 195.99 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales172.43195.99 -12 OPM %14.2415.01 -PBDT24.7934.18 -27 PBT20.1929.89 -32 NP13.8521.27 -35Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content